Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome

British Journal of Haematology
Nancy A KernanPaul Richardson

Abstract

Hepatic veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) is a potentially life-threatening complication of haematopoietic stem cell transplant (HSCT) conditioning and chemotherapy. Defibrotide is approved for treatment of hepatic VOD/SOS with pulmonary or renal dysfunction [i.e., multi-organ dysfunction (MOD)] after HSCT in the United States and severe VOD/SOS after HSCT in patients aged older than 1 month in the European Union. Defibrotide was available as an investigational drug by an expanded-access treatment programme (T-IND; NCT00628498). In the completed T-IND, the Kaplan-Meier estimated Day +100 survival for 1000 patients with documented defibrotide treatment after HSCT was 58·9% [95% confidence interval (CI), 55·7-61·9%]. Day +100 survival was also analysed by age and MOD status, and post hoc analyses were performed to determine Day +100 survival by transplant type, timing of VOD/SOS onset (≤21 or >21 days) and timing of defibrotide treatment initiation after VOD/SOS diagnosis. Day +100 survival in paediatric patients was 67·9% (95% CI, 63·8-71·6%) and 47·1% (95% CI, 42·3-51·8%) in adults. All patient subgroups without MOD had higher Day +100 survival than those with MOD; earlier defibrotide initiation w...Continue Reading

References

Jul 20, 1993·European Journal of Pharmacology·G BianchiG Prino
Oct 26, 1999·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·J L LeeG B McDonald
Nov 21, 2007·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Enric CarrerasUNKNOWN Spanish Myeloma Group/PETHEMA
Sep 22, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Jason A CoppellDietger Niederwieser
Oct 8, 2009·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Cinara L EchartMassimo Iacobelli
Feb 20, 2010·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Paul G RichardsonEva C Guinan
Dec 6, 2012·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Kasiani C MyersSonata Jodele
Dec 12, 2012·Expert Opinion on Drug Safety·Paul G RichardsonRobert Soiffer
May 18, 2013·Vascular Pharmacology·R PescadorM E Ferrero
Oct 10, 2013·British Journal of Haematology·Fiona L DignanUNKNOWN British Society for Blood and Marrow Transplantation
Apr 26, 2016·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Christopher StrouseWael Saber
Jul 12, 2016·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Selim CorbaciogluPaul Richardson
Mar 13, 2017·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Paul G RichardsonUNKNOWN Defibrotide Study Group
Sep 25, 2017·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Nicholas J GloudeKasiani C Myers

❮ Previous
Next ❯

Citations

Oct 24, 2018·Pediatric Blood & Cancer·Anselm Chi-Wai Lee, LeLe Aung
Mar 14, 2019·Pediatric Blood & Cancer·Simone CesaroGianni Bisogno
Oct 28, 2019·International Journal of Hematology·Naohito FujishimaMasayuki Hino
Feb 13, 2019·Journal of the National Cancer Institute·Bradley D Hunter, Caron A Jacobson
Jul 21, 2020·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·William TappeMassimo Iacobelli
Oct 18, 2019·ACG Case Reports Journal·Tooba TariqMurray Ehrinpreis
Apr 23, 2020·Frontiers in Immunology·Francesca BonifaziAntonio Colecchia
Apr 23, 2020·British Journal of Haematology·Gerhard C Hildebrandt, Nelson Chao
Oct 17, 2019·Frontiers in Pediatrics·Andrew R GenneryUNKNOWN Inborn Errors Working Party (IEWP) of the European Society for Blood and Marrow Transplantation (EBMT)
Dec 15, 2019·Clinical Journal of the American Society of Nephrology : CJASN·Amanda DeMauro RenaghanMitchell Howard Rosner
Oct 6, 2020·Frontiers in Oncology·Kimberly FanSaad Ghafoor
Dec 12, 2018·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Madeleine ThemannsEva Zebedin-Brandl
Oct 11, 2020·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Varun MehraShreyans Gandhi
Sep 21, 2020·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Paul G RichardsonStephan A Grupp
Nov 5, 2019·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Clinton LewisVincent T Ho
Mar 26, 2021·International Journal of Hematology·Mutsumi NishidaTakanori Teshima
Mar 31, 2021·Transplantation and Cellular Therapy·Patrick Hagen, Nasheed Hossain
Mar 23, 2020·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Selim CorbaciogluPaul G Richardson
Jul 14, 2021·Bone Marrow Transplantation·Thomas LuftAleksandar Radujkovic
Nov 4, 2021·Pediatric Radiology·Anneloes E BohteMaarten H Lequin
Dec 14, 2021·The Korean Journal of Internal Medicine·Seom Gim KongHo Sup Lee

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT00628498

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.